General Information
Product name
Amphotericin B for Injection, USP
Product name
Amphotericin B for Injection, USP
Identification on the label/Trade name
Not available
Product Synonyms
Not available
Chemical name
Amphotericin B
CAS No.
1397-89-3
Emergency telephone
1-800-222-1222
Icons in SDS
Company Information
company name
X-GEN Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Potential Acute Health Effects
Hazardous in case of skin contact (irritant), or inhalation
Potential chronic health
Effects Hazardous in case of skin contact (irritant), or inhalation Carcinogenic Effects: Not available Mutagenic Effects: Not available
Teratogenic Effects
Some studies in animals have not shown that Amphotericin B causes adverse effects on the fetus; however, some studies involving rabbits at twice the recommended human dose revealed a higher rate of miscarriage. Developmental Toxicity: The substance is toxic to blood, cardiovascular system, upper respiratory tract. Repeated or prolonged exposure to the substance can produce target organ damage. Adverse effects: Adverse effects following ingestion may include nausea, vomiting, diarrhea; adverse effects following topical application may include burning, itching, redness or other signs of irritation. Systemic effects following injection include unusual tiredness, irregular heartbeat, muscle cramps or pain, change in urination, blurred or double vision, itching, trouble breathing, wheezing, tightness in chest, sore throat, fever, shaking from chills, numbness, tingling, pain or weakness in hands or feet, seizures, unusual bleeding or bruising, indigestion, loss of appetite, stomach pain, leg, back, or neck pain, headache, and dizziness. Possible allergic reaction to material if inhaled, ingested or in contact with skin.
